Lp(a): should we go after it? Should it modify our lipid targets?

Back

ESC Premium Access

Lp(a): should we go after it? Should it modify our lipid targets?

Session: The Primary Prevention Summit

Topic: Lipids (Epidemiology and Prevention)

Speaker: Professor J. Chapman (Paris, FR)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)

17 presentations

0 follower

4 more presentations in this session

SPRINT and HOPE3: implications for the treatment of hypertension.

Speaker: Doctor S. Yusuf (Hamilton, CA)

Access

Slides

Video

How much exercise is needed to prevent heart disease?

Speaker: Doctor C. Lavie (New Orleans, US)

Access

Slides

Video

"Statins for life"? The effect of statins on survival in primary prevention.

Speaker: Professor P. Greenland (Chicago, US)

Access

Slides

Video

"Plaque but no obstructive coronary disease" - Primary or secondary prevention?

Speaker: Professor S. Halvorsen (Oslo, NO)

Access

Slides

Video

Access the full session

The Primary Prevention Summit

Speakers: Professor J. Chapman, Doctor S. Yusuf, Doctor C. Lavie, Professor P. Greenland, Professor S. Halvorsen

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Lp(a): should we go after it? Should it modify our lipid targets?

About the speaker

Professor John Chapman

4 more presentations in this session

SPRINT and HOPE3: implications for the treatment of hypertension.

How much exercise is needed to prevent heart disease?

"Statins for life"? The effect of statins on survival in primary prevention.

"Plaque but no obstructive coronary disease" - Primary or secondary prevention?

Access the full session

The Primary Prevention Summit

About the event

ESC Congress 2017

ESC 365 is supported by